Cargando…

DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application

DNA methylation, an epigenetic modification, regulates gene transcription and maintains genome stability. DNA methyltransferase (DNMT) inhibitors can activate silenced genes at low doses and cause cytotoxicity at high doses. The ability of DNMT inhibitors to reverse epimutations is the basis of thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Chunhong, Liu, Xiaohan, Zeng, Yue, Liu, Junqi, Wu, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394595/ https://www.ncbi.nlm.nih.gov/pubmed/34452630 http://dx.doi.org/10.1186/s13148-021-01154-x

Ejemplares similares

Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases
por: Kanwal, Rajnee, et al.
Publicado: (2016)

Correction: Dietary Flavones as Dual Inhibitors of DNA Methyltransferases and Histone Methyltransferases
por: Kanwal, Rajnee, et al.
Publicado: (2016)

New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
por: Gros, Christina, et al.
Publicado: (2015)

Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”?
por: Brunner, Andrew M., et al.
Publicado: (2022)

Epigenetic Variation Induced by Gamma Rays, DNA Methyltransferase Inhibitors, and Their Combination in Rice
por: Lee, Sung-Il, et al.
Publicado: (2020)

Expanding the Structural Diversity of DNA Methyltransferase Inhibitors
por: Juárez-Mercado, K. Eurídice, et al.
Publicado: (2020)

Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
por: Chen, Rui, et al.
Publicado: (2020)

Mechanisms of DNA Methyltransferase Recruitment in Mammals
por: Laisné, Marthe, et al.
Publicado: (2018)

The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors
por: Chen, Rui, et al.
Publicado: (2020)

In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1
por: Miletić, Vedran, et al.
Publicado: (2017)

Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancer
por: Luo, Na, et al.
Publicado: (2018)

DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
por: Dan, Huimin, et al.
Publicado: (2019)

Recent progress in DNA methyltransferase inhibitors as anticancer agents
por: Zhang, Zhixiong, et al.
Publicado: (2022)

DNA methyltransferase inhibitor exposure–response: Challenges and opportunities
por: Kagan, Amanda B., et al.
Publicado: (2023)

DNA Methyltransferases: From Evolution to Clinical Applications
por: Del Castillo Falconi, Victor M., et al.
Publicado: (2022)

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors
por: Koustas, Evangelos, et al.
Publicado: (2020)

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
por: Laranjeira, Angelo B. A., et al.
Publicado: (2023)

Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors
por: Kalinin, Stanislav, et al.
Publicado: (2021)

Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells
por: Miyara, Makoto, et al.
Publicado: (2016)

Antitumor Effect of Simvastatin in Combination With DNA Methyltransferase Inhibitor on Gastric Cancer via GSDME-Mediated Pyroptosis
por: Xia, Ying, et al.
Publicado: (2022)

The Role and Mechanism of Lysine Methyltransferase and Arginine Methyltransferase in Kidney Diseases
por: Zhou, Xun, et al.
Publicado: (2022)

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
por: Gravina, Giovanni L, et al.
Publicado: (2010)

DNA methylation and DNA methyltransferases
por: Edwards, John R., et al.
Publicado: (2017)

Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review)
por: Jin, Ning, et al.
Publicado: (2023)

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)

Exploration of the Potential Transcriptional Regulatory Mechanisms of DNA Methyltransferases and MBD Genes in Petunia Anther Development and Multi-Stress Responses
por: Shi, Lisha, et al.
Publicado: (2022)

The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer
por: Shi, Bin, et al.
Publicado: (2022)

Inhibitors of DNA Methyltransferases From Natural Sources: A Computational Perspective
por: Saldívar-González, Fernanda I., et al.
Publicado: (2018)

DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts
por: Yonemura, Hitomi, et al.
Publicado: (2019)

QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors
por: Phanus-umporn, Chuleeporn, et al.
Publicado: (2020)

Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase
por: Zhou, Jujun, et al.
Publicado: (2023)

Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports
por: Zeng, Yue, et al.
Publicado: (2022)

Complex DNA sequence readout mechanisms of the DNMT3B DNA methyltransferase
por: Dukatz, Michael, et al.
Publicado: (2020)

The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer
por: Luker, Andrea J., et al.
Publicado: (2020)

Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
por: Ahn, Ryuhjin, et al.
Publicado: (2021)

Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model
por: Deng, Xin, et al.
Publicado: (2019)

Effect of DNA Methyltransferase in Comparison to and in Combination with Histone Deacetylase Inhibitors on Hepatocellular Carcinoma HepG2 Cell Line
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Selective Inhibitors of Protein Methyltransferases
por: Kaniskan, H. Ümit, et al.
Publicado: (2014)

Synthesis of lysine methyltransferase inhibitors
por: Hui, Chunngai, et al.
Publicado: (2015)

Inhibitors of Protein Methyltransferases and Demethylases
por: Kaniskan, H. Ümit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sg6dn8l655e1hmeehsuu2jcels